Detection of Lymph Node Micrometastases by Gene Promoter Hypermethylation in Samples Obtained by Endosonography- Guided Fine-Needle Aspiration Biopsy

Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) has become a fundamental procedure for gastrointestinal and lung cancer staging. However, there is growing evidence that micrometastases are present in lymph nodes, which cannot be detected with standard pathological methods. The aim of this study was to evaluate whether hypermethylation gene promoter analysis was feasible on samples obtained by EUS-FNA from lymph nodes, as well as to establish the usefulness of this strategy for the detection of micrometastases in patients with gastrointestinal and non-small cell lung cancer. Suspicious lymph nodes based on EUS findings from consecutive patients with esophageal, gastric, rectal, and non-small cell lung cancer were sampled by EUS-FNA. Hypermethylation analysis of the MGMT, p16INK4a, and p14ARF gene promoter CpG islands were performed by methylation-specific PCR. Effectiveness of conventional cytology, methylation analysis, and their combination were established with respect to the definitive diagnosis. Twenty-seven patients were included, thus representing a total of 42 lymph nodes (esophageal cancer, n = 11; rectal cancer, n = 7; gastric cancer, n = 3; and lung cancer, n = 21). According to definitive diagnosis, 21 (50%) corresponded to metastatic lymph nodes. Sensitivity, specificity, and overall accuracy of conventional cytology were 76%, 100%, and 88%, respectively, whereas the corresponding values for the methylation analysis were 81%, 67%, and 74%, respectively. Combination of both techniques increased sensitivity (90%) but decreased specificity (67%) with respect to conventional cytology. In conclusion, it is feasible to detect occult neoplastic cells in EUS-FNA samples by hypermethylation gene promoter analysis. Moreover, addition of methylation analysis to conventional cytology may increase its sensitivity at the expenses of a decrease in its specificity.

[1]  C. Lopes,et al.  Detection of gene promoter hypermethylation in fine needle washings from breast lesions. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  Nicole Benoit,et al.  p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study. , 2003, Journal of the National Cancer Institute.

[3]  E. T. Jones,et al.  Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer. , 2003, American journal of respiratory and critical care medicine.

[4]  M. Esteller.  Relevance of DNA methylation in the management of cancer. , 2003, The Lancet. Oncology.

[5]  J. Llach,et al.  Clinical usefulness of KRAS mutational analysis in the diagnosis of pancreatic adenocarcinoma by means of endosonography‐guided fine‐needle aspiration biopsy , 2003, Alimentary pharmacology & therapeutics.

[6]  S. Goodman,et al.  Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  A. Lacy,et al.  Prognostic Value of Postoperative Detection of Blood Circulating Tumor Cells in Patients With Colorectal Cancer Operated on For Cure , 2003, Annals of surgery.

[8]  C. Earle,et al.  An analysis of multiple staging management strategies for carcinoma of the esophagus: computed tomography, endoscopic ultrasound, positron emission tomography, and thoracoscopy/laparoscopy. , 2002, The Annals of thoracic surgery.

[9]  Javier Benitez,et al.  Cancer Epigenetics and Methylation , 2002, Science.

[10]  Y. Shiratori,et al.  Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor , 2002, American Journal of Gastroenterology.

[11]  M. Esteller.  CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.

[12]  J. Olson,et al.  A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. , 2002, Gastroenterology.

[13]  W. Leung,et al.  Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  M. Brock,et al.  Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study. , 2002, The Journal of thoracic and cardiovascular surgery.

[15]  M. Wiersema,et al.  A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer , 2002, American Journal of Gastroenterology.

[16]  P. Laird,et al.  DNA Methylation: An Alternative Pathway to Cancer , 2001, Annals of surgery.

[17]  Kenneth K Wang,et al.  Impact of EUS-guided fine-needle aspiration on lymph node staging in patients with esophageal carcinoma. , 2001, Gastrointestinal endoscopy.

[18]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[19]  A. Lacy,et al.  Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer. , 2001, Gastroenterology.

[20]  J. Hayashi,et al.  Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases. , 2000, Cancer research.

[21]  R. Erickson,et al.  Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. , 2000, Gastrointestinal endoscopy.

[22]  D. Sidransky,et al.  Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  J. Herman,et al.  Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. , 1999, Cancer research.

[24]  G. Capellá,et al.  K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  L. Boix,et al.  Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction. , 1998, British Journal of Cancer.

[26]  O. Cummings,et al.  Endoscopic Ultrasonography, Fine-Needle Aspiration Biopsy Guided by Endoscopic Ultrasonography, and Computed Tomography in the Preoperative Staging of Non-Small-Cell Lung Cancer: A Comparison Study , 1997, Annals of Internal Medicine.

[27]  K. Sugimachi,et al.  Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer. , 1997, The Journal of thoracic and cardiovascular surgery.

[28]  J. Jen,et al.  Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Minna,et al.  Aberrant promoter methylation of multiple genes in non-small cell lung cancers. , 2001, Cancer research.

[31]  S. Baylin,et al.  Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. , 2000, Cancer research.

[32]  M E Burt,et al.  Incidence of local recurrence and second primary tumors in resected stage I lung cancer. , 1995, The Journal of thoracic and cardiovascular surgery.